Literature DB >> 6142901

Effects of chronic beta-receptor stimulation on sympathetic nervous system activity, energy expenditure, and thyroid hormones.

K Scheidegger, M O'Connell, D C Robbins, E Danforth.   

Abstract

The effects of hyper- and hypothyroidism on sympathetic nervous system activity and energy expenditure are well recognized. The impact of altered sympathetic nervous system activity on energy expenditure and thyroid hormone metabolism has not been well studied. We investigated the effects of orally administered terbutaline sulfate, a beta 2-receptor agonist (5 mg, three times per day for 2 weeks), on the activity of the sympathetic nervous system, energy expenditure, and thyroid hormone metabolism in six normal men, aged 21-36 yr. The cardiovascular, metabolic, and thermogenic responses to an infusion of the beta-adrenergic agonist isoproterenol were clearly blunted after 2 weeks of treatment with terbutaline sulfate, indicating down-regulation of beta-receptors and/or development of reduced sensitivity. There were no significant changes in the cardiovascular, metabolic, or thermogenic responses to an infusion of the alpha-adrenergic agonist phenylephrine. Basal metabolic rate was significantly increased by the chronic administration of terbutaline sulfate [5.040 +/- 0.167 (+/- SE) vs. 5.421 +/- 0.234 kJ/min; P less than 0.05]. There was a highly significant change in the serum T3 to T4 ratio (19.4 +/- 1.0 vs. 24.4 +/- 1.0; P less than 0.001). This was a result of increased serum T3 concentrations (136 +/- 9 vs. 160 +/- 14 ng/dl; P less than 0.05) and decreased serum T4 concentrations (7.2 +/- 0.8 vs. 6.7 +/- 0.8 micrograms/dl; P = NS). Chronic beta-receptor stimulation with terbutaline sulfate increases the basal metabolic rate and T3 concentrations. These changes occurred despite down-regulation of beta-receptors and/or decreased sensitivity in response to chronic terbutaline administration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6142901     DOI: 10.1210/jcem-58-5-895

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

Review 2.  Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue.

Authors:  Y T Yang; M A McElligott
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

3.  Modification of the thermogenic effect of acutely inhaled salbutamol by chronic inhalation in normal subjects.

Authors:  S R Wilson; P Amoroso; J Moxham; J Ponte
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

4.  Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease.

Authors:  L Burdet; B de Muralt; Y Schutz; J W Fitting
Journal:  Thorax       Date:  1997-02       Impact factor: 9.139

5.  Minimal changes in environmental temperature result in a significant increase in energy expenditure and changes in the hormonal homeostasis in healthy adults.

Authors:  Francesco S Celi; Robert J Brychta; Joyce D Linderman; Peter W Butler; Anna Teresa Alberobello; Sheila Smith; Amber B Courville; Edwin W Lai; Rene Costello; Monica C Skarulis; Gyorgy Csako; Alan Remaley; Karel Pacak; Kong Y Chen
Journal:  Eur J Endocrinol       Date:  2010-09-08       Impact factor: 6.664

6.  Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine.

Authors:  E M Erfurth; P Hedner
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

7.  Acute effects of inhaled salbutamol on the metabolic rate of normal subjects.

Authors:  P Amoroso; S R Wilson; J Moxham; J Ponte
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

8.  Effects of terbutaline on basal thermogenesis of human skeletal muscle and Na-K pump after 1 week of oral use--a placebo controlled comparison with propranolol.

Authors:  B Fagher; H Liedholm; A Sjögren; M Monti
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

9.  Thermogenic and lipolytic effect of yohimbine in the dog.

Authors:  J Galitzky; M Vermorel; M Lafontan; P Montastruc; M Berlan
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

Review 10.  The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.

Authors:  Jonathan R S Arch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.